BioLineRx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.

About BLRX

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. 

CEO
Philip Adam Serlin
CEOPhilip Adam Serlin
Employees
28
Employees28
Headquarters
Modi'in, HaMerkaz
HeadquartersModi'in, HaMerkaz
Founded
2003
Founded2003
Employees
28
Employees28

BLRX Key Statistics

Market cap
11.17M
Market cap11.17M
Price-Earnings ratio
-0.66
Price-Earnings ratio-0.66
Dividend yield
—
Dividend yield—
Average volume
19.31K
Average volume19.31K
High today
$3.07
High today$3.07
Low today
$2.93
Low today$2.93
Open price
$3.00
Open price$3.00
Volume
14.11K
Volume14.11K
52 Week high
$35.60
52 Week high$35.60
52 Week low
$2.30
52 Week low$2.30
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.